Re: | Bank of America Corporation | |||
Amendment No. 1 to Registration Statement on Form S-4 | ||||
Filed March 27, 2008 | ||||
File No. 333-149204 | ||||
Bank of America Corporation | ||||
Form 10-K for December 31, 2007, filed February 28, 2008 | ||||
Schedule 14A filed March 19, 2008 | ||||
File Number 001-06523 |
1. | In your response to prior comment 3, you indicated that Bank of America does not believe that the decision as to how the outstanding obligations of Countrywide will be backed by Bank of America is material to a voting or investment decision by the shareholders of Countrywide. The staff is not able to agree with this analysis, as it appears that the decision to guarantee or assume the outstanding debt of Countrywide would materially affect the financial health of Bank of America and therefore could be material to a voting decision in which the result of the transaction would be the exchange of Countrywide shares for shares of Bank of America. Therefore, please provide the information requested by prior comment 3, or provide analysis as to how the decision to assume or guarantee the debt of Countrywide is not material to Bank of America or its shareholders. | |
In response to the Staffs comment, we have provided additional disclosure on page 58. |
2. | We note your response to our former comment 6; please consider adding disclosure relating to the current FBI investigation into securities fraud at Countrywide (as first reported in the Wall Street Journal on March 8, 2008) and any foreseeable impact it may have on the merger. | |
The Department of Justice has stated that it cannot confirm or deny whether it is conducting an investigation, and, therefore, Countrywide cannot confirm the accuracy of news accounts about an FBI investigation. Countrywide supplementally advises the Staff that it has no reason to anticipate that the news reports or any underlying facts or circumstances would have any impact on the merger. |
3. | Revise this section to specifically note that some of the analysis performed by Countrywides financial advisors did not support the overall fairness determination and state whether the board considered this factor in arriving at its recommendation. | |
In response to the Staffs comment, we have revised the disclosure on page 29. |
4. | The disclosure added in response to prior comment 14 does not clearly indicate that the amounts disclosed represent all compensation paid to the financial advisors or merely the fees paid for the described services. Please clarify that the amounts represent all compensation paid to each of the financial service providers, rather than the amounts paid for certain types of services. | |
In response to the Staffs comment, we have revised the disclosure on page 32. |
5. | Please revise the last paragraph of your legality opinion; you can limit your opinion as to scope but not person. | |
In response to the Staffs comment, we have revised the last paragraph of our legality opinion. | ||
6. | We note that you disclaim your obligation to update your opinion; accordingly, please represent to staff that you intend to file this opinion immediately prior to effectiveness or give your opinion as of the date of effectiveness rather than the date hereof. | |
We hereby confirm that we intend to file the legality opinion immediately prior to effectiveness of the Form S-4. |
7. | We note that you administer three multi-seller conduits to which you provide liquidity, standby letters of credit or similar loss protection commitments. Please tell us and revise future filings to provide detailed disclosures regarding your obligations under these liquidity facilities. Consider providing the following in your revised disclosures: |
| Whether your obligation is to purchase commercial paper, provide capital commitments or to purchase assets from the conduits; | ||
| Whether there are triggers associated with your obligations to fund; and | ||
| Whether there are any terms that would limit your obligation to perform. |
We will expand our future filings to provide additional details pertaining to our commitments to the multi-seller conduits as follows: |
| Our liquidity, standby letters of credit (SBLC) and similar loss protection commitments obligate us to purchase assets from the conduits at the conduits cost. Subsequent realized losses on assets purchased from the unconsolidated conduits would be reimbursed from the cash received from the sale of capital notes and equity interests to third party investors. We would absorb losses in excess of such amounts. | ||
| If a conduit is unable to re-issue commercial paper due to illiquidity in the commercial paper market or deterioration in the asset portfolio, we are obligated to provide funding subject to certain limitations, as described below. | ||
| Our obligations to purchase assets under the SBLC and similar loss protection commitments are subject to a maximum commitment amount, which is typically set at 8% to 10% of the total outstanding commercial paper. Our obligation to purchase assets under the liquidity agreements, which comprise the remainder of our exposure, is generally limited to the amount of non-defaulted assets. We are not obligated to fund under the liquidity, SBLC or similar loss protection commitments if the conduit is the subject of a voluntary or involuntary bankruptcy proceeding. |
8. | We note your disclosure regarding liquidity support provided to other corporate conduits. It indicates that in the event that you are unable to remarket the conduits commercial paper such that it no longer qualifies as a QSPE, you would consolidate the conduit. Please confirm that the reason the QSPE status could be invalidated is due to the requirement in paragraph 36 of SFAS 140. Additionally, in light of your obligation to purchase assets from the vehicles if the assets or insurers are downgraded, please tell us how you concluded that the SPE met the criteria to qualify as a QSPE. | |
We confirm that QSPE status of the other corporate conduits could be invalidated due to the requirements in paragraph 36 of SFAS 140. As indicated in paragraph 35(a) of SFAS 140, a QSPE must be ...demonstrably distinct from the transferor. Paragraph 36 indicates that if a QSPE is not a guaranteed mortgage securitization it is demonstrably distinct from the transferor only if it cannot be unilaterally dissolved by the transferor, its affiliates, or its agents and at least 10 percent of the fair value of its beneficial interests is held by parties other than the transferor, its affiliates, or its agents. Consequently, if one or more of our corporate conduits were unable to remarket a sufficient percentage of its commercial paper to meet this test, that conduit would no longer be a QSPE because it would no longer be demonstrably distinct from the transferor (i.e., Bank of America Corporation) and we would consolidate. | ||
Paragraph 35(d)(1) of SFAS 140 permits a QSPE to sell assets in an automatic response to the occurrence of an event or circumstance that (a) is specified in the legal documents |
(a) | The liquidity agreements were established at the time the conduits were created. | ||
(b) | The sale of an asset is triggered by the downgrade of the issuer or insurer of that asset or an event of default by the issuer. Such events are outside of our control. | ||
(c) | At the time of transfer into the conduit, each asset is typically rated AAA based on the rating of the issuer or the insurer, as applicable. If an asset is downgraded below AA-, the conduit is required to sell the asset. Such a downgrade from the initial rating will cause the fair value of the asset to decline. |
9. | We note you provided $12.3 billion of liquidity support to CDO vehicles during 2007, of which $9.1 billion was provided to unconsolidated CDOs. Please tell us how you determined that you were not the primary beneficiary of these vehicles in light of the liquidity support provided. Address the following in your response: |
| Tell us whether you considered the written put options and other liquidity agreements to be variable interests at the inception of the CDO transactions, and if so, how those variable interests impacted the primary beneficiary calculation at inception and at each reconsideration event; |
Our written put options and other liquidity obligations to unconsolidated CDOs at December 31, 2007 included support of $2.3 billion to a CDO conduit that we administer (the Conduit) and $6.8 billion to third party CDOs (the Third Party CDO Issuers). | ||
As discussed in more detail below in response to the second part of this comment, we performed a quantitative FIN 46(R) analysis for the Conduit at its inception in 2005. We concluded that we were not the primary beneficiary. However, given our role as administrator and liquidity provider, we concluded that we held a significant variable interest in the Conduit and it would be appropriate to include the Conduit in our FIN 46(R) disclosures. | ||
The Conduit holds only super senior CDO tranches, and we consider the purchase of each new asset by the Conduit to be a reconsideration event. At the time of each reconsideration event, we reaffirmed our conclusion that we were not the primary beneficiary. However, during 2007, we did not perform any quantitative tests as no new assets were purchased by the Conduit. | ||
Although we exercised our right as administrator to remove certain assets from the Conduit during the fourth quarter of 2007 due to credit deterioration, we did not consider the removal of these assets to be a reconsideration event because the actions were taken in accordance with pre-existing legal arrangements. Finally, we did not consider the purchase of commercial paper (CP) issued by the Conduit during 2007 to be a reconsideration event because it did not expose us to any new risk or variability, as discussed in more detail below in response to the third part of this comment. As no reconsideration events occurred in 2007, we did not perform a reconsideration analysis for the Conduit in 2007. | ||
As discussed in more detail below, we performed qualitative analyses for each of the Third Party CDO Issuers and concluded that we were not the primary beneficiary. | ||
All of our liquidity obligations to Third Party CDO Issuers arose prior to June 30, 2007. We did not consider these obligations to be significant variable interests at inception of the transactions based on the following: |
| Clarify whether you performed a quantitative or qualitative analysis to determine whether you were the primary beneficiary of these CDO vehicles at inception and at each reconsideration event; |
| Explain whether you consider the purchase of commercial paper from the vehicles to be reconsideration events under paragraph 15 of FIN 46(R) and clarify whether your conclusion is different for commercial paper purchased pursuant to written put options, other liquidity agreements, or non-contractually required purchases; |
| Clarify whether the commercial paper purchases during the second half of 2007 were in all cases made pursuant to the terms of the liquidity puts, or whether certain purchases were made in advance of any specific obligation to purchase the commercial paper; and |
| Clarify the terms of the written put options, including how severe disruption in the short-term funding market is defined. Explain whether it is solely based on whether the CDO can issue commercial paper at prices below the contractual yield specified in your liquidity obligations. |
10. | We note that you consolidated a CDO vehicle to which you provided liquidity support of $3.2 billion as of December 31, 2007. Please explain whether this CDO was newly-created during 2007 or whether it was an existing CDO for which you became the primary beneficiary during 2007. If the latter, please describe the events that resulted in the change in primary beneficiary determination and explain how your consolidation analysis resulted in a different conclusion for this CDO compared to the other unconsolidated CDOs to which you provided liquidity support. | |
The consolidated CDO was newly-created early in the second quarter of 2007. At that time, we concluded that we were not the primary beneficiary because the liquidity support that we provided for the super senior tranches of CP would not absorb a significant amount of variability. Later in the second quarter, we acquired all of the mezzanine securities issued by the vehicle. At the time of this acquisition, which was a reconsideration event, we determined that the equity tranches held by third parties were essentially worthless and concluded that we were the primary beneficiary. We therefore consolidated this CDO. |
11. | Please describe the types of derivative contracts utilized in conjunction with the asset acquisition conduits that you administer on behalf of your customers. Consider providing this disclosure in future filings to the extent material. | |
Assets are acquired by the unconsolidated asset acquisition conduits at the request of a customer who wishes to benefit from the economic returns of the specified asset on a leveraged basis. We are not the transferor of such assets. At the time the conduit acquires an asset, we enter into back-to-back total return swaps with the conduit and the customer such that the economic returns of the assets are passed through to the customer. | ||
In future filings, we will clarify that the derivative contracts utilized in conjunction with the asset acquisition conduits that we administer on behalf of our customers are total return swaps. |
12. | We note your disclosure concerning your concentrations of credit risk in certain states (e.g. California, Florida) with respect to your consumer loan portfolio. In light of the significant deterioration in the housing markets in certain geographical |
areas, please consider disclosing the delinquency statistics (e.g. charge-offs, nonperforming, accruing past due 90 days) related to your residential mortgage and home equity loan portfolios in these states in your future filings. Consider providing this information in a tabular format similar to Table 13. | ||
In future filings, we will review delinquency statistics for significant declines. As appropriate, we will disclose delinquency statistics for states where we have concentrations of credit risk and significant housing market deterioration exists. |
13. | In the table on page 105 we note your disclosure regarding your exposure to credit derivatives, and specifically the 103% increase in notional amount of credit derivatives from $1.5 trillion at December 31, 2006 to $3.0 trillion at December 31, 2007. To the extent material and applicable, please consider revising your future filings to address the following types of disclosures regarding your credit derivatives either here or in your MD&A: |
a. | Quantify the extent to which the positions held in your credit derivatives portfolio represent a purchase of credit default protection versus a sale of credit default protection, as well as the types of instruments used (e.g., total return swaps, credit default swaps, or other credit derivatives). Within these two categories of protection sold and purchased, please separately quantify the extent to which the derivative activity was for the following purposes: |
| Provide default risk protection to offset credit exposure to your holdings of the related reference entitys debt in your loan portfolio, investment portfolio or loan commitments outstanding; | ||
| Create new credit risk positions for your own trading purposes; | ||
| Create new credit exposures taken for the benefit of your clients; and | ||
| Provide an offset to credit exposure taken for the benefit of clients. |
b. | Separately quantify the gross realized gains and losses from your credit derivative activity. | ||
c. | Consider discussing the settlement triggers that are typical to the swap contracts in your credit derivatives portfolio. To the extent that the nature of the triggers varies within your portfolio, discuss that fact accordingly. | ||
d. | Discuss the overall strategies you employ in your credit derivatives portfolio as well as any changes in those strategies during the periods presented. |
e. | Discuss any trends experienced within the portfolio both in terms of positions held and realized gains and losses. Specifically disclose the reasons for the significant increases in the notional amounts as well as the reasons for the changes in the credit risk of the derivatives. Discuss any expected changes to those trends. | ||
f. | Discuss the types of counterparties (e.g. broker-dealers, other financial institutions, non-financial institutions, and insurance and financial guaranty firms) to your credit derivatives, and consider quantifying the notional amount of credit derivatives by type of counterparty, separated based on whether you purchased protection from the counterparty or sold protection to the counterparty. | ||
g. | Discuss, in general terms, the potential impact to you should one of the counterparties to the credit derivatives contract experience a downgrade in their credit rating. |
We acknowledge your points included in items (a) through (g). To the extent material and applicable, we will provide the suggested disclosures in our periodic filings. |
14. | In future filings, please present the value of the equity awards made to directors based upon the amounts expensed on the awards during the fiscal year. Please refer to Item 402(k)(iii) and the accompanying instructions. | |
We have reviewed Item 402(k)(iii) of Regulation S-K and the accompanying instructions and believe that our Proxy Statement for our 2008 Annual Meeting of Stockholders fully complies. We request that you clarify the nature of your comment. | ||
15. | In future filings, please refrain from adding columns to the Director Compensation Table or otherwise changing the format of the table. Instead, if you believe that investors might benefit from more explanation as to the results reported in the table, please present the information in the footnotes or in an accompanying narrative discussion. | |
The Director Compensation Table (the Table) in the Proxy Statement for our 2008 Annual Meeting of Stockholders includes all the information required by Item 402(k)(iii) of Regulation S-K. For stock awards, this item requires disclosure of the dollar amount recognized for financial statement reporting purposes with respect to the fiscal year. The amounts expensed under FAS 123R in our 2007 financial statements include amounts related to awards in 2007 and prior years. In order for our stockholders to understand the compensation that was provided to our directors for their service in 2007, as well as the |
amount expensed for their prior years service, we subdivided the Stock Awards column. Nevertheless, we also included a Total Stock Awards column, which includes the full dollar amount expensed under FAS 123R, and this amount is reflected in the Total column in the Table. Thus, we believe that the inclusion of the additional columns provides valuable information to our stockholders in an easy-to-understand format and would prefer to include this information in the Table rather than in a footnote or in narrative disclosure. We note that other companies, including JPMorganChase & Co., also have followed a similar approach. |